Senseonics Holdings, Inc. (NYSE:SENS) Shares Bought by Jane Street Group LLC

Jane Street Group LLC lifted its position in Senseonics Holdings, Inc. (NYSE:SENS - Free Report) by 6,694.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,118,786 shares of the company's stock after purchasing an additional 6,028,726 shares during the period. Jane Street Group LLC owned 1.03% of Senseonics worth $3,203,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of SENS. First Light Asset Management LLC purchased a new stake in Senseonics during the fourth quarter worth $3,366,000. Northern Trust Corp lifted its holdings in Senseonics by 11.2% during the fourth quarter. Northern Trust Corp now owns 1,194,960 shares of the company's stock worth $625,000 after buying an additional 120,441 shares during the period. Beck Mack & Oliver LLC purchased a new stake in Senseonics during the fourth quarter worth $79,000. XTX Topco Ltd purchased a new stake in Senseonics during the fourth quarter worth $179,000. Finally, Raymond James Financial Inc. purchased a new stake in Senseonics during the fourth quarter worth $26,000. Hedge funds and other institutional investors own 12.36% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on SENS shares. Mizuho began coverage on Senseonics in a report on Thursday, April 10th. They set an "outperform" rating and a $2.00 target price for the company. StockNews.com upgraded Senseonics to a "sell" rating in a report on Monday, May 12th. Finally, HC Wainwright reiterated a "buy" rating and set a $2.00 price objective on shares of Senseonics in a report on Wednesday, March 5th.

Senseonics Stock Down 3.6%

Shares of SENS traded down $0.02 during midday trading on Friday, hitting $0.53. 33,811,369 shares of the company's stock traded hands, compared to its average volume of 6,544,971. Senseonics Holdings, Inc. has a 1 year low of $0.25 and a 1 year high of $1.40. The firm's fifty day moving average is $0.65 and its 200-day moving average is $0.63. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The stock has a market capitalization of $346.73 million, a price-to-earnings ratio of -4.08 and a beta of 1.05.

Senseonics (NYSE:SENS - Get Free Report) last issued its quarterly earnings data on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same period in the previous year, the business posted ($0.07) EPS. As a group, sell-side analysts anticipate that Senseonics Holdings, Inc. will post -0.14 earnings per share for the current year.

Senseonics Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.